PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs
Visit https://www.peervoice.com/PSA860 to view the entire programme with slides. After completing “Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs”, participants will be able to: Describe the unmet treatment needs in patients with advanced non–small-cell lung cancer (NSCLC), and in particular MET exon 14 (METex14) skipping mutations; Summarise the impact of METex14 mutation on patient outcomes; and Discuss current and emerging treatment options for patients with METex14 mutations.